The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) has recently released new guidelines on best practice methods to diagnose Clostridium difficile infection (CDI). The latest document updates the original 2009 guidelines and includes recommendations concerning the use of new diagnostic technology such as nucleic acid amplification tests (NAAT). The study that underpins the new guidelines was initiated in June 2014.
Read more on guidelines: C. difficile infection (CDI) and updates to the guidelines
Reference: ESCMID Updates C. difficile Diagnostic Guidelines. 24.8.2016. http://www.infectioncontroltoday.com/news/2016/08/escmid-updates-c-difficile-diagnostic-guidelines.aspx
Molecular btesting for healthier life
Orion Diagnostica’s C. difficile test, Orion GenRead C. difficile was launched in the spring 2015. Orion GenRead is a flexible benchtop solution including a small instrument and ready to use kits. It is intended for rapid detection of pathogens, offering a fast, affordable and accurate alternative for nucleic acid testing in various laboratory settings.
Orion GenRead is based on Orion Diagnostica’s proprietary isothermal nucleic acid amplification technology, SIBA® (Strand Invasion Based Amplification).
Orion GenRead C. difficile test is available.
SIBA (Strand Invasion Based Amplification) is Orion Diagnostica’s proprietary isothermal nucleic acid amplification technology. The technology is based on amplification of nucleic acids at a constant temperature of 40 degrees Celsius.
Orion GenRead C. difficile